Sep 14, 2023
Kathy Ford is the Chief Product and Strategy Officer at Ronin, applying AI and deep data mining to determine relevant cohorts to develop better cancer treatment plans. Looking at patient-specific data, including genetics, comorbidities, and risk factors, allows medical oncologists and patients to predict results and...
Sep 14, 2023
Kathy Ford is the Chief Product and Strategy Officer at Ronin, applying AI and deep data mining to determine relevant cohorts to develop better cancer treatment plans. Looking at patient-specific data, including genetics, comorbidities, and risk factors, allows medical oncologists and patients to predict results and...
Aug 15, 2023
Dr. Fahar Merchant, President, CEO, and Co-Founder of Medicenna Therapeutics, talks about the role cytokines play in managing the immune system, activating the system, or dampening the immune response depending on the circumstances. When the system is out of balance, pathogens and cancers can attack, or autoimmune...
Aug 15, 2023
Dr. Fahar Merchant, President, CEO, and Co-Founder of Medicenna Therapeutics, talks about the role cytokines play in managing the immune system, activating the system, or dampening the immune response depending on the circumstances. When the system is out of balance, pathogens and cancers can attack, or autoimmune...
Aug 2, 2023
Dr. Tariq Arshad is the Senior Vice President and Chief Medical Officer at Qualigen Therapeutics, addressing multiple types of RAS-driven cancers. While researchers understand RAS's role in tumorgenesis and have identified which cancers are RAS-driven, RAS has been considered an undruggable target. With a pan-RAS...